What is the projected market valuation of the Precision Genomic Testing Market by 2035?

The Precision Genomic Testing Market is projected to reach a valuation of 41.46 USD Billion by 2035. Read More

What was the market valuation of the Precision Genomic Testing Market in 2024?

In 2024, the market valuation of the Precision Genomic Testing Market was 15.54 USD Billion. Read More

What is the expected CAGR for the Precision Genomic Testing Market during the forecast period 2025 - 2035?

The expected CAGR for the Precision Genomic Testing Market during the forecast period 2025 - 2035 is 9.33%. Read More

Which testing methodologies are leading in the Precision Genomic Testing Market?

Next-Generation Sequencing and Polymerase Chain Reaction are leading methodologies, with valuations projected at 16.0 USD Billion and 10.0 USD Billion respectively by 2035. Read More

What are the primary application areas for Precision Genomic Testing?

Oncology and Cardiology are primary application areas, with projected valuations of 17.2 USD Billion and 8.0 USD Billion respectively by 2035. Read More

What types of samples are predominantly used in Precision Genomic Testing?

Tissue Samples and Saliva Samples are predominantly used, with projected valuations of 13.0 USD Billion and 10.5 USD Billion respectively by 2035. Read More

Who are the key players in the Precision Genomic Testing Market?

Key players in the market include Illumina, Thermo Fisher Scientific, Roche, and Myriad Genetics, among others. Read More

What are the main product types in the Precision Genomic Testing Market?

Consumables and Instruments are main product types, with projected valuations of 13.0 USD Billion and 10.0 USD Billion respectively by 2035. Read More

Which end users are driving the Precision Genomic Testing Market?

Hospitals and Diagnostic Centers are driving the market, with projected valuations of 13.0 USD Billion and 10.0 USD Billion respectively by 2035. Read More

How does the Precision Genomic Testing Market compare across different segments?

The market shows varied growth across segments, with Oncology leading in application areas and Next-Generation Sequencing in testing methodologies. Read More

Precision Genomic Testing Market

Precision Genomic Testing Market Research Report By Testing Methodology (Next-Generation Sequencing, Polymerase Chain Reaction, Microarray Analysis, Sanger Sequencing), By Application Area (Oncology, Cardiology, Neurology, Infectious Diseases, Prenatal Testing), By Sample Type (Blood Samples, Tissue Samples, Saliva Samples, Urine Samples), By End User (Hospitals, Research Laboratories, Diagnostic Centers, Pharmaceutical Companies), By Product Type (Consumables, Instruments, Software, Services) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

9.33%

2024 Market Size

$ 15.54 Billion

2035 Market Size

$ 41.46 Billion

Healthcare ● Updated April 2026 Report ID: MRFR/HC/30411-HCR | Pages: 100 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Testing Methodology (USD Billion)
  1. 4.1.1 Next-Generation Sequencing
  2. 4.1.2 Polymerase Chain Reaction
  3. 4.1.3 Microarray Analysis
  4. 4.1.4 Sanger Sequencing
2. 4.2 Healthcare, BY Application Area (USD Billion)
  1. 4.2.1 Oncology
  2. 4.2.2 Cardiology
  3. 4.2.3 Neurology
  4. 4.2.4 Infectious Diseases
  5. 4.2.5 Prenatal Testing
3. 4.3 Healthcare, BY Sample Type (USD Billion)
  1. 4.3.1 Blood Samples
  2. 4.3.2 Tissue Samples
  3. 4.3.3 Saliva Samples
  4. 4.3.4 Urine Samples
4. 4.4 Healthcare, BY End User (USD Billion)
  1. 4.4.1 Hospitals
  2. 4.4.2 Research Laboratories
  3. 4.4.3 Diagnostic Centers
  4. 4.4.4 Pharmaceutical Companies
5. 4.5 Healthcare, BY Product Type (USD Billion)
  1. 4.5.1 Consumables
  2. 4.5.2 Instruments
  3. 4.5.3 Software
  4. 4.5.4 Services
6. 4.6 Healthcare, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Illumina (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Roche (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Agilent Technologies (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Qiagen (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Myriad Genetics (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Bristol-Myers Squibb (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Guardant Health (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Fulgent Genetics (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TESTING METHODOLOGY
4. 6.4 US MARKET ANALYSIS BY APPLICATION AREA
5. 6.5 US MARKET ANALYSIS BY SAMPLE TYPE
6. 6.6 US MARKET ANALYSIS BY END USER
7. 6.7 US MARKET ANALYSIS BY PRODUCT TYPE
8. 6.8 CANADA MARKET ANALYSIS BY TESTING METHODOLOGY
9. 6.9 CANADA MARKET ANALYSIS BY APPLICATION AREA
10. 6.10 CANADA MARKET ANALYSIS BY SAMPLE TYPE
11. 6.11 CANADA MARKET ANALYSIS BY END USER
12. 6.12 CANADA MARKET ANALYSIS BY PRODUCT TYPE
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY TESTING METHODOLOGY
15. 6.15 GERMANY MARKET ANALYSIS BY APPLICATION AREA
16. 6.16 GERMANY MARKET ANALYSIS BY SAMPLE TYPE
17. 6.17 GERMANY MARKET ANALYSIS BY END USER
18. 6.18 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
19. 6.19 UK MARKET ANALYSIS BY TESTING METHODOLOGY
20. 6.20 UK MARKET ANALYSIS BY APPLICATION AREA
21. 6.21 UK MARKET ANALYSIS BY SAMPLE TYPE
22. 6.22 UK MARKET ANALYSIS BY END USER
23. 6.23 UK MARKET ANALYSIS BY PRODUCT TYPE
24. 6.24 FRANCE MARKET ANALYSIS BY TESTING METHODOLOGY
25. 6.25 FRANCE MARKET ANALYSIS BY APPLICATION AREA
26. 6.26 FRANCE MARKET ANALYSIS BY SAMPLE TYPE
27. 6.27 FRANCE MARKET ANALYSIS BY END USER
28. 6.28 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
29. 6.29 RUSSIA MARKET ANALYSIS BY TESTING METHODOLOGY
30. 6.30 RUSSIA MARKET ANALYSIS BY APPLICATION AREA
31. 6.31 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE
32. 6.32 RUSSIA MARKET ANALYSIS BY END USER
33. 6.33 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
34. 6.34 ITALY MARKET ANALYSIS BY TESTING METHODOLOGY
35. 6.35 ITALY MARKET ANALYSIS BY APPLICATION AREA
36. 6.36 ITALY MARKET ANALYSIS BY SAMPLE TYPE
37. 6.37 ITALY MARKET ANALYSIS BY END USER
38. 6.38 ITALY MARKET ANALYSIS BY PRODUCT TYPE
39. 6.39 SPAIN MARKET ANALYSIS BY TESTING METHODOLOGY
40. 6.40 SPAIN MARKET ANALYSIS BY APPLICATION AREA
41. 6.41 SPAIN MARKET ANALYSIS BY SAMPLE TYPE
42. 6.42 SPAIN MARKET ANALYSIS BY END USER
43. 6.43 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY TESTING METHODOLOGY
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATION AREA
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY END USER
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY TESTING METHODOLOGY
51. 6.51 CHINA MARKET ANALYSIS BY APPLICATION AREA
52. 6.52 CHINA MARKET ANALYSIS BY SAMPLE TYPE
53. 6.53 CHINA MARKET ANALYSIS BY END USER
54. 6.54 CHINA MARKET ANALYSIS BY PRODUCT TYPE
55. 6.55 INDIA MARKET ANALYSIS BY TESTING METHODOLOGY
56. 6.56 INDIA MARKET ANALYSIS BY APPLICATION AREA
57. 6.57 INDIA MARKET ANALYSIS BY SAMPLE TYPE
58. 6.58 INDIA MARKET ANALYSIS BY END USER
59. 6.59 INDIA MARKET ANALYSIS BY PRODUCT TYPE
60. 6.60 JAPAN MARKET ANALYSIS BY TESTING METHODOLOGY
61. 6.61 JAPAN MARKET ANALYSIS BY APPLICATION AREA
62. 6.62 JAPAN MARKET ANALYSIS BY SAMPLE TYPE
63. 6.63 JAPAN MARKET ANALYSIS BY END USER
64. 6.64 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY TESTING METHODOLOGY
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATION AREA
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY END USER
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
70. 6.70 MALAYSIA MARKET ANALYSIS BY TESTING METHODOLOGY
71. 6.71 MALAYSIA MARKET ANALYSIS BY APPLICATION AREA
72. 6.72 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE
73. 6.73 MALAYSIA MARKET ANALYSIS BY END USER
74. 6.74 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
75. 6.75 THAILAND MARKET ANALYSIS BY TESTING METHODOLOGY
76. 6.76 THAILAND MARKET ANALYSIS BY APPLICATION AREA
77. 6.77 THAILAND MARKET ANALYSIS BY SAMPLE TYPE
78. 6.78 THAILAND MARKET ANALYSIS BY END USER
79. 6.79 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
80. 6.80 INDONESIA MARKET ANALYSIS BY TESTING METHODOLOGY
81. 6.81 INDONESIA MARKET ANALYSIS BY APPLICATION AREA
82. 6.82 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE
83. 6.83 INDONESIA MARKET ANALYSIS BY END USER
84. 6.84 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
85. 6.85 REST OF APAC MARKET ANALYSIS BY TESTING METHODOLOGY
86. 6.86 REST OF APAC MARKET ANALYSIS BY APPLICATION AREA
87. 6.87 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE
88. 6.88 REST OF APAC MARKET ANALYSIS BY END USER
89. 6.89 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY TESTING METHODOLOGY
92. 6.92 BRAZIL MARKET ANALYSIS BY APPLICATION AREA
93. 6.93 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE
94. 6.94 BRAZIL MARKET ANALYSIS BY END USER
95. 6.95 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
96. 6.96 MEXICO MARKET ANALYSIS BY TESTING METHODOLOGY
97. 6.97 MEXICO MARKET ANALYSIS BY APPLICATION AREA
98. 6.98 MEXICO MARKET ANALYSIS BY SAMPLE TYPE
99. 6.99 MEXICO MARKET ANALYSIS BY END USER
100. 6.100 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
101. 6.101 ARGENTINA MARKET ANALYSIS BY TESTING METHODOLOGY
102. 6.102 ARGENTINA MARKET ANALYSIS BY APPLICATION AREA
103. 6.103 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE
104. 6.104 ARGENTINA MARKET ANALYSIS BY END USER
105. 6.105 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TESTING METHODOLOGY
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION AREA
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY TESTING METHODOLOGY
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION AREA
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY END USER
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY TESTING METHODOLOGY
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION AREA
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY END USER
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
122. 6.122 REST OF MEA MARKET ANALYSIS BY TESTING METHODOLOGY
123. 6.123 REST OF MEA MARKET ANALYSIS BY APPLICATION AREA
124. 6.124 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE
125. 6.125 REST OF MEA MARKET ANALYSIS BY END USER
126. 6.126 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY TESTING METHODOLOGY, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY TESTING METHODOLOGY, 2024 TO 2035 (USD Billion)
135. 6.135 HEALTHCARE, BY APPLICATION AREA, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY APPLICATION AREA, 2024 TO 2035 (USD Billion)
137. 6.137 HEALTHCARE, BY SAMPLE TYPE, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion)
139. 6.139 HEALTHCARE, BY END USER, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
141. 6.141 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.2.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.2.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.2.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.2.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.3.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.3.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.3.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.3.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.4.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.4.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.4.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.4.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.5.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.5.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.5.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.5.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.6.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.6.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.6.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.6.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.7.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.7.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.7.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.7.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.8.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.8.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.8.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.8.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.9.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.9.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.9.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.9.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.10.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.10.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.10.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.10.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.11.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.11.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.11.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.11.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.12.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.12.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.12.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.12.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.13.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.13.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.13.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.13.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.14.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.14.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.14.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.14.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.15.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.15.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.15.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.15.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.16.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.16.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.16.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.16.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.17.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.17.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.17.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.17.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.18.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.18.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.18.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.18.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.19.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.19.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.19.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.19.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.20.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.20.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.20.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.20.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.21.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.21.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.21.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.21.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.22.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.22.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.22.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.22.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.23.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.23.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.23.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.23.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.24.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.24.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.24.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.24.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.25.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.25.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.25.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.25.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.26.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.26.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.26.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.26.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.27.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.27.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.27.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.27.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.28.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.28.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.28.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.28.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.29.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.29.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.29.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.29.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TESTING METHODOLOGY, 2025-2035 (USD Billion)
  2. 7.30.2 BY APPLICATION AREA, 2025-2035 (USD Billion)
  3. 7.30.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  4. 7.30.4 BY END USER, 2025-2035 (USD Billion)
  5. 7.30.5 BY PRODUCT TYPE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Precision Genomic Testing Market Segmentation

Precision Genomic Testing Market By Testing Methodology (USD Billion, 2025-2035)

Next-Generation Sequencing
Polymerase Chain Reaction
Microarray Analysis
Sanger Sequencing

Precision Genomic Testing Market By Application Area (USD Billion, 2025-2035)

Oncology
Cardiology
Neurology
Infectious Diseases
Prenatal Testing

Precision Genomic Testing Market By Sample Type (USD Billion, 2025-2035)

Blood Samples
Tissue Samples
Saliva Samples
Urine Samples

Precision Genomic Testing Market By End User (USD Billion, 2025-2035)

Hospitals
Research Laboratories
Diagnostic Centers
Precision Genomic Testing Market Companies

Precision Genomic Testing Market By Product Type (USD Billion, 2025-2035)

Consumables
Instruments
Software
Services

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”